Is Sanmina Corp. overvalued or undervalued?

As of 28 July 2025, the valuation grade for Sanmina Corp. has moved from attractive to very attractive, indicating a stronger position in the market. Based on the current metrics, the company appears to be undervalued, with a P/E ratio of 32, an EV to EBITDA of 17.00, and a Price to Book Value of 3.85. In comparison to peers, Sanmina's P/E ratio is significantly lower than that of Masimo Corp. at 179.74, while Globus Medical, Inc. shows a more favorable P/E of 18.37.
The company's performance has outpaced the S&P 500, with a year-to-date return of 57.75% compared to the S&P 500's 12.22%, and a one-year return of 74.59% against 17.14% for the index. This robust performance further supports the view that Sanmina Corp. is currently undervalued in the market.